Avestar Capital, LLC Ionis Pharmaceuticals Inc Transaction History

Avestar Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $88,885 - $108,585	-1,505 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$62.09 - $86.14 $25,518 - $35,403	411 Added 37.57%	1,505 $82,000
Q1 2019 May 09, 2019	SELL	$52.92 - $81.17 $21,326 - $32,711	-403 Reduced 26.92%	1,094 $71,000
Q4 2018 Jan 25, 2019	SELL	$43.37 - $59.54 $9,888 - $13,575	-228 Reduced 13.22%	1,497 $60,000
Q3 2018 Oct 23, 2018	SELL	$42.88 - $53.7 $2,658 - $3,329	-62 Reduced 3.47%	1,725 $65,000
Q2 2018 Aug 10, 2018	BUY	$40.53 - $50.7 $22,494 - $28,138	555 Added 45.05%	1,787 $56,000
Q1 2018 May 10, 2018	BUY	$44.08 - $55.05 $6,391 - $7,982	145 Added 13.34%	1,232 $35,000
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $54,676 - $69,991	1,087	1,087 $36,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.